BioCardia, Inc. financial data

Symbol
BCDA on Nasdaq
Location
320 Soquel Way, Sunnyvale, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 83.5 % +96.4%
Debt-to-equity 7.64K %
Return On Equity -19.1K % -3729%
Return On Assets -247 % +11.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.8M shares +173%
Common Stock, Shares, Outstanding 5.5M shares +159%
Entity Public Float 5.6M USD -88.3%
Common Stock, Value, Issued 6K USD +200%
Weighted Average Number of Shares Outstanding, Basic 5.06M shares +170%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 5.24M USD +3.45%
Costs and Expenses 8.85M USD -1.99%
Operating Income (Loss) -8.85M USD -2.88%
Nonoperating Income (Expense) 60K USD +27.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -8.79M USD -2.75%
Earnings Per Share, Basic -1 USD/shares +78.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 980K USD -31%
Accounts Receivable, after Allowance for Credit Loss, Current 10K USD 0%
Assets, Current 1.2M USD -23.8%
Property, Plant and Equipment, Net 17K USD -72.1%
Operating Lease, Right-of-Use Asset 702K USD -35.3%
Other Assets, Noncurrent 171K USD 0%
Assets 2.09M USD -27.7%
Accounts Payable, Current 1.23M USD -14.8%
Accrued Liabilities, Current 41K USD +925%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 3.64M USD -10.5%
Operating Lease, Liability, Noncurrent 333K USD -57.3%
Liabilities 3.98M USD -18.1%
Retained Earnings (Accumulated Deficit) -165M USD -5.63%
Stockholders' Equity Attributable to Parent -1.89M USD +3.83%
Liabilities and Equity 2.09M USD -27.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.62M USD -5.75%
Net Cash Provided by (Used in) Financing Activities 196K USD -85.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 5.5M shares +159%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.42M USD -823%
Deferred Tax Assets, Valuation Allowance 38.5M USD +4.86%
Deferred Tax Assets, Gross 38.5M USD +4.86%
Operating Lease, Liability 745K USD -34.5%
Depreciation 48K USD -37.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 807K USD -37.9%
Property, Plant and Equipment, Gross 795K USD +0.51%
Operating Lease, Liability, Current 412K USD +15.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 514K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 249K USD -50.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 62K USD -61.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 44K USD 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 1.78M USD +5.84%
Lessee, Operating Lease, Liability, to be Paid, Year Four 44K USD -91.4%
Operating Lease, Payments 372K USD +15.9%
Additional Paid in Capital 163M USD +5.75%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 12K USD -36.8%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 621K USD -24.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%